@FierceMedDev: Boston Scientific launches a new clinical trial of its deep brain stimulation device. More | Follow @FierceMedDev
@VarunSaxena2: Deerfield bets on robotic surgery with OMNIlife science deal. Article | Follow @VarunSaxena2
@EmilyWFierce: "Molecular tweezers" could help prevent degenerative diseases like Alzheimer's or Parkinson's, say scientists at UCLA. Article | Follow @EmilyWFierce
@MichaelGFierce: ICYMI: 'Computer' made with DNA nanorobots delivers compounds in live cockroach. More from FierceDrugDelivery | Follow @MichaelGFierce
> The U.K.'s Lombard Medical has postponed its plans to go public in a $60 million IPO, citing unfavorable market conditions. News
> Diagnostics outfit Bio-Rad Laboratories ($BIO) has acquired DNA sequencing company GnuBIO for an undisclosed sum. More
> Seno Medical won a CE mark for its Imagio breast imaging system. Item
Biotech News
@FierceBiotech: Chimerix CEO Moch steps down after compassionate-use controversy. More | Follow @FierceBiotech
@JohnCFierce: Bayer backs VC fund, FBI calls Russian VCs thieves, Oryzon and Serendex plan IPOs. EuroBiotech Report | Follow @JohnCFierce
@DamianFierce: As Gilead gets pilloried over pricing, Bristol-Myers Squibb (Report) and Merck (Report) creep up in hep C. | Follow @DamianFierce
@EmilyMFierce: 'Not messing around': Ill. health official taking infectious tuberculosis patient to court. Story | Follow @EmilyMFierce
> Three IPO hopefuls look to squeeze out $144M as biotech gets bearish. News
> VCs gamble $45M on PhII pain drug, new U.S. base for Spinifex. More
> AbbVie angles for hep C spotlight as Merck shoulders to the front. Story
Pharma News
@FiercePharma: Natco looking to block Indian patent for Gilead's Sovaldi. Story | Follow @FiercePharma
@TracyStaton: FiercePharma's best-read marketing story: Sanofi aims for outcomes with new Chief Patient Officer. More | Follow @TracyStaton
@EricPFierce: RT from FiercePharma: AbbVie partners with Arabio for production in Saudi Arabia. Article | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Our latest issue of FierceVaccines. More | Follow @CarlyHFierce
> Second drug spending report predicts double-digit increases coming. News